Zinc sulphate matrices for the individual therapy of Wilson¿s disease - Zelkó, Romána;Nagy, Judit
35,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
18 °P sammeln
  • Broschiertes Buch

Zinc is now one of the recommended therapies for the long-term management of Wilson s disease. Zinc has shown clinical efficacy at doses of 50 mg three times daily in the stimulation of metallothionein synthesis and reduction of copper absorption. The mean plasma elimination half-lives of most highly water soluble drugs, like zinc sulphate, are relatively short (2-4.5 h), which necessitates several applications a day. Long-acting sustained and controlled release preparations make a once-a-day dose treatment possible, thus improving the patients compliance. The rate and extent of drug release…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Zinc is now one of the recommended therapies for the long-term management of Wilson s disease. Zinc has shown clinical efficacy at doses of 50 mg three times daily in the stimulation of metallothionein synthesis and reduction of copper absorption. The mean plasma elimination half-lives of most highly water soluble drugs, like zinc sulphate, are relatively short (2-4.5 h), which necessitates several applications a day. Long-acting sustained and controlled release preparations make a once-a-day dose treatment possible, thus improving the patients compliance. The rate and extent of drug release from most controlled release wax matrices are influenced by several factors including the drug loading/embedding excipient ratio of the systems. The changing of this ratio enabled the preparation of zinc sulphate wax matrices of required drug release kinetics consequently of plasma zinc level.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Pharmacist, full-time Professor of the Faculty of Pharmacy of the Semmelweis University Publications: 5 book chapters, 2 books, 2 patents, 118 journal articles. Professional interest: polymeric excipients, physical ageing of biomaterials, physical stability of dosage forms, quality aspects of dosage forms, design of drug delivery systems.